From: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
HLN | PART | MEAN | RANGE | MLN | PART | MEAN | RANGE |
---|---|---|---|---|---|---|---|
SF | 5% | 0–8% | SF | 28% | 7–41% | ||
HSP60 | PC | 2% | 0–4% | HSP60 | PC | 2% | 0–4% |
MS | 1% | 0–2% | MS | 3% | 0–6% | ||
SF | 13% | 4–22% | SF | 35% | 18–58% | ||
HSP10 | PC | 5% | 2–8% | HSP10 | PC | 9% | 4–19% |
MS | 3% | 1–5% | MS | 38% | 22–65% |